Catalyst Wire Dossier Catalyst Wire Dossier

ORACEA

Doxycycline · Galderma Laboratories, L.P.
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for ORACEA, covering 2006-05-26 to 2025-04-02. Get the full timeline:

Most recent: FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)

See pricing